Chemoinformaics analysis of 3-oxo-olean-12-en-28-oic-acid
| Molecular Weight | 178.231 | nRot | 3 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 17 |
| Exact Molecular Weight | 178.099 | nRing | 1 |
| Solubility: LogS | -4.019 | nHRing | 0 |
| Solubility: LogP | 3.734 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 29.3091 |
| nHD | 0 | BPOL | 17.5169 |
| QED | 0.85 |
| Synth | 3.837 |
| Natural Product Likeliness | 2.168 |
| NR-PPAR-gamma | 0.928 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.007 |
| HIA | 0.004 |
| CACO-2 | -4.796 |
| MDCK | 0.0000224 |
| BBB | 0.222 |
| PPB | 0.9443 |
| VDSS | 0.347 |
| FU | 0.0619721 |
| CYP1A2-inh | 0.036 |
| CYP1A2-sub | 0.87 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.926 |
| CYP2c9-inh | 0.112 |
| CYP2c9-sub | 0.609 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.216 |
| CYP3a4-inh | 0.053 |
| CYP3a4-sub | 0.464 |
| CL | 0.788 |
| T12 | 0.131 |
| hERG | 0.009 |
| Ames | 0.018 |
| ROA | 0.289 |
| SkinSen | 0.626 |
| Carcinogencity | 0.055 |
| EI | 0.375 |
| Respiratory | 0.573 |
| NR-Aromatase | 0.211 |
| Antiviral | No |
| Prediction | 0.698089 |